» Articles » PMID: 38867251

Impact of Mobile Application and Outpatient Follow-up on Renal Endpoints and Physiological Indices in Patients with Chronic Kidney Disease: a Retrospective Cohort Study in Southwest China

Overview
Publisher Biomed Central
Date 2024 Jun 12
PMID 38867251
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic kidney disease (CKD) is a significant public health concern, and patient self-management is an effective approach to manage the condition. Mobile applications have been used as tools to assist in improving patient self-management, but their effectiveness in long-term outpatient follow-up management of patients with CKD remains to be validated. This study aimed to investigate whether using a mobile application combined with traditional outpatient follow-up can improve health outcomes of patients with CKD .

Methods: This retrospective cohort study recruited CKD patients with stage 1-5 who were not receiving renal replacement therapy from a CKD management center. Two groups were established: the APP + outpatient follow-up group and the traditional outpatient follow-up group. Baseline data was collected from January 2015 to December 2019, followed by a three-year long-term follow-up until December 2022. Laboratory data, all-cause mortality, and renal replacement treatment were then collected and compared between the two groups.

Results: 5326 patients were included in the study, including 2492 in the APP + outpatient group and 2834 in the traditional outpatient group. After IPTW virtualization matching, the final matched the APP + outpatient group consisted of 2489 cases (IQR, 33-55) and 2850 (IQR, 33-55) in the traditional outpatient group. By the end of the study, it was observed that the laboratory data of Phosphorus, Sodium, Triglyceride, Hemoglobin showed significant improvements, Furthermore the APP + outpatient group demonstrated superior results compared to the traditional outpatient group (P < .05). And it was observed that there were 34 deaths (1.4%) in the APP + outpatient group and 46 deaths (1.6%) in the traditional outpatient group(P = .49). After matching for renal replacement therapy outcomes, the two groups were found to be comparable (95% CI [0.72-1.08], P = .23), with no significant difference. However, it was noted that the traditional outpatient group had a lower incidence of using temporary catheters during initial hemodialysis (95% CI [8.4-29.8%], P < .001).

Conclusion: The development and application of an app combined with outpatient follow-up management can improve patient health outcomes. However, to ensure optimal preparation for kidney replacement therapy, patients in CKD stages 4-5 may require more frequent traditional outpatient follow-ups, and further develop an information-based decision-making support tool for renal replacement therapy.

References
1.
Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T . Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021; 42(40):4111-4122. PMC: 8530534. DOI: 10.1093/eurheartj/ehab559. View

2.
Kelly J, Warner M, Conley M, Reidlinger D, Hoffmann T, Craig J . Feasibility and acceptability of telehealth coaching to promote healthy eating in chronic kidney disease: a mixed-methods process evaluation. BMJ Open. 2019; 9(1):e024551. PMC: 6352771. DOI: 10.1136/bmjopen-2018-024551. View

3.
Blakey J, Bender B, Dima A, Weinman J, Safioti G, Costello R . Digital technologies and adherence in respiratory diseases: the road ahead. Eur Respir J. 2018; 52(5). PMC: 6364097. DOI: 10.1183/13993003.01147-2018. View

4.
Lv J, Zhang L . Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019; 1165:3-15. DOI: 10.1007/978-981-13-8871-2_1. View

5.
Westas M, Lundgren J, Andersson G, Mourad G, Johansson P . Effects of Internet-delivered cognitive behavioural therapy adapted for patients with cardiovascular disease and depression: a long-term follow-up of a randomized controlled trial at 6 and 12 months posttreatment. Eur J Cardiovasc Nurs. 2022; 21(6):559-567. DOI: 10.1093/eurjcn/zvab131. View